E1: US Response to COVID-19 & Impact on Startups, VC & Public Markets with David Friedberg

ℹ️ EPISODE INFO

Released

March 19, 2020

Duration

1h 31m

Channel

All-In Podcast

Watch on YouTube

▶ Open ↗

📝 EPISODE DESCRIPTION

0:01 Jason & Chamath intro David and check in on each other's quarantines 2:26 Has the US overreacted or underreacted so far? David & Chamath give their opinions on new directives & statistics 13:15 Thoughts on potential treatment options & policy changes 22:25 Chamath explains the circumstances of recording a podcast while the Stock Market tanks in real-time 25:03 Should the US adopt Chinese & South Korean quarantine strategies? 29:53 What do the current market conditions mean for startups & VC? 41:24 Chamath explains what is currently happening in the capital markets 45:05 How close is the US on being able to do mass-testing? 54:13 Thoughts on bailouts for companies that manipulated their earnings-per-share ratio by stock buybacks? Impact on the global economy 1:03:14 Impact on luxury goods? Should there be a monthly stipend for low-income citizens? 1:12:10 COVID-19 exposing holes in the US healthcare system 1:17:44 Should we ban wet markets globally? 1:24:12 Over/Under: when Americans will be allowed to go out to restaurants again 1:28:18 When will the weekly poker game resume?

🎤 SPEAKERS

• Jason Calacanis

  host

• Chamath Palihapitiya

  host

• David Friedberg

  host

🧾 EPISODE SUMMARY

In this episode of All-In Podcast, featuring Jason Calacanis and Chamath Palihapitiya, E1: US Response to COVID-19 & Impact on Startups, VC & Public Markets with David Friedberg explores cOVID-19, Markets, and Startups: Data, Testing, and Economic Reckoning The episode explores the early U.S. response to COVID-19 across three fronts: public health, government policy, and financial markets. David Friedberg argues that policy is being made on incomplete data, especially undercounted asymptomatic cases, which likely overstates fatality rates and justifies overly blunt shutdowns.

🔗 RELATED EPISODES

SpaceX-Cursor Deal, SaaS Debt Bomb, New Apple CEO, SPLC Indictment, Colon Cancer Spike

Anthropic’s $30B Ramp, Mythos Doomsday, OpenClaw Ankled, Iran War Ceasefire, Israel's Influence

Elon’s Anthropic Deal, The Next AI Monopoly?, “FDA for AI” Panic, Trading the AI Boom

OpenAI's Identity Crisis, Datacenter Wars, Market Up on Iran News, Mamdani's First Tax, Swalwell Out

OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

Jensen Huang: Nvidia's Future, Physical AI, Rise of the Agent, Inference Explosion, AI PR Crisis